Scribd Logo
Importer

Bienvenue sur Scribd !

  • Ranitidine Drug Summ

    Transféré par

    Warren
    12K vues1 page
    This document summarizes information about the drug Ranitidine (Zantac). It lists Ranitidine as an antiulcer drug classified for short-term treatment of active duodenal ulcers and benign gastric ulcers. It is dosed at 50 mg every 8 hours intravenously or orally. Ranitidine works by inhibiting the action of histamine at the H2 receptor site in the gastric parietal cells, resulting in inhibition of gastric acid secretion. Potential side effects include confusion, arrhythmias, and drug-induced hepatitis. Nursing implications include assessing for signs of ulcers before administration and administering the drug with meals to prolong its effects.

    Description originale:

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Formats disponibles

    DOC, PDF, TXT ou lisez en ligne sur Scribd

    Avez-vous trouvé ce document utile ?

    Ce contenu est-il inapproprié ?

    Signaler ce document
    This document summarizes information about the drug Ranitidine (Zantac). It lists Ranitidine as an antiulcer drug classified for short-term treatment of active duodenal ulcers and benign gastric ulcers. It is dosed at 50 mg every 8 hours intravenously or orally. Ranitidine works by inhibiting the action of histamine at the H2 receptor site in the gastric parietal cells, resulting in inhibition of gastric acid secretion. Potential side effects include confusion, arrhythmias, and drug-induced hepatitis. Nursing implications include assessing for signs of ulcers before administration and administering the drug with meals to prolong its effects.

    Droits d'auteur :

    Attribution Non-Commercial (BY-NC)
    Téléchargez comme DOC, PDF, TXT ou lisez en ligne sur Scribd
    Signaler comme contenu inapproprié
    12K vues1 page

    Ranitidine Drug Summ

    Transféré par

    Warren
    This document summarizes information about the drug Ranitidine (Zantac). It lists Ranitidine as an antiulcer drug classified for short-term treatment of active duodenal ulcers and benign gastric ulcers. It is dosed at 50 mg every 8 hours intravenously or orally. Ranitidine works by inhibiting the action of histamine at the H2 receptor site in the gastric parietal cells, resulting in inhibition of gastric acid secretion. Potential side effects include confusion, arrhythmias, and drug-induced hepatitis. Nursing implications include assessing for signs of ulcers before administration and administering the drug with meals to prolong its effects.

    Droits d'auteur :

    Attribution Non-Commercial (BY-NC)
    Téléchargez comme DOC, PDF, TXT ou lisez en ligne sur Scribd
    Signaler comme contenu inapproprié
    sur 1

    Score: _________ Grade: _____________

    DRUG SUMMARY

    Name of Drug Date Classificatio Dose Mechanism Specific Side Effects Nursing Implications
    Generic Ordered n Frequency of Action Indication
    (Brand) Route

    Ranitidine Antiulcer 50 mg Inhibits the Short-term CNS: confusion, BEFORE:


    agents q8hr action of treatment of dizziness, drowsiness, >Assess patient for epigastric or
    (Zantac) hallucinations,
    IVTT histamine at active abdominal pain and frank or
    headache. occult blood in the stool, emesis,
    the H2- duodenal CV: ARRHYTHMIAS. or gastric aspirate.
    receptor site ulcers and GI: altered taste, black >Assess geriatric and debilitated
    located benign tongue (ranitidine patients routinely for confusion.
    primarily in gastric bismuth citrate only), Report promptly.
    constipation, dark
    gastric parietal ulcers stools (ranitidine
    cells, resulting bismuth citrate only), DURING:
    in inhibition of diarrhea, drug-induced >Administer over at least 5 min.
    gastric acid hepatitis (nizatidine, Rapid administration may cause
    secretion cimetidine), nausea. hypotension and arrhythmias.
    GU: decreased sperm
    count, impotence. AFTER:
    In addition, Endo: gynecomastia. >Ranitidine may cause false-
    ranitidine Hemat: positive results for urine protein;
    bismuth citrate AGRANULOCYTOSIS, test with sulfosalicylic acid.
    has some APLASTIC ANEMIA, >Administer with meals or
    anemia, neutropenia, immediately afterward and at
    antibacterial thrombocytopenia. bedtime to prolong effect.
    action against Local: pain at IM site.
    H. pylori. Misc: hypersensivity
    reactions.

    Reference: DAVIS DRUG GUIDE FOR NURSES 8th EDITION___

    Vous aimerez peut-être aussi